2291.HK - 心泰醫療

HKSE - HKSE 延遲價格。貨幣為 HKD。


Building 41
1st Floor, 5th Floor No. 258, Xinzhuan Road Songjiang District
Shanghai 201612
86 21 3701 5600

行業Medical Devices


Ms. Juan ChenExec. Chairman & GM232.59k1972
Ms. Yuxin ZhangDeputy GM, CTO & Exec. Director160.71k1979
Mr. Xue QinDeputy GM, CFO & Joint Company Sec.1976
Mr. Yufeng HeDeputy GM & COO1982
Ms. Xiani ZhangDeputy Gen. Mang.1985
Ms. Ka Man Ng A.C.I.S., A.C.S., ACIS, ACSJoint Company Sec.1978
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。


LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occluder products; treatment of valvular disease solutions comprising aortic valve products, mitral valve products, tricuspid valve products, pulmonary valve products, and procedural accessories; and vascular plugs and interatrial shunt devices. The company offers its products primarily to distributors and hospitals. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.


截至 無 止,心泰醫療 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。